Skip to main content
Clinical Trials/DRKS00026087
DRKS00026087Completed未知

Optical genome mapping in addition to cytogenetic characterization based on apparently balanced chromosome translocations

niversitätsklinikum FreiburgInstitut für Humangenetik0 sites4 target enrollmentStarted: August 13, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
4

Study Overview

Brief Summary

We emphasize the importance of a combination of conventional cytogenetics and molecular cytogenomic methods (e.g., OGM) to reveal the cause of monogenic diseases typically caused by single nucleotide variants. The combination of those different techniques in cases of reciprocally balanced translocations involving the FBN1 gene is helpful to understand the extent of the molecular etiology of Marfan syndrome. Thus, it has the potential to identify novel, clinically relevant FBN1 gene abnormalities that expand the diagnostic possibilities in patients with Marfan syndrome.

Study Design

Study Type
Interventional
Allocation
N/a: Single Arm Study
Masking
Open (masking not used)

Eligibility Criteria

Ages
one to one (—)
Sex
All

Inclusion Criteria

  • apparently balanced chromosome translocations

Exclusion Criteria

  • inconspicuous set of chromosomes

Investigators

Sponsor
niversitätsklinikum FreiburgInstitut für Humangenetik

Similar Trials